Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Incidence of potential adverse events during hospital-based ketogenic diet initiation among children with drug-resistant epilepsy
This finding is consistently observed in all stratified analysis for all subgroups
The presence of short-chain fatty acids (SCFAs) in the gut can effectively lower the pH of the intestinal lumen, thereby exerting inhibitory effects on the proliferation of pathogenic microorganisms
It is being developed primarily as a treatment for obesity and type 2 diabetes, but its potential applications extend to several weight-related conditions including non-alcoholic fatty liver disease (NAFLD), knee osteoarthritis, and obstructive sleep apnoea
US$ 23.16
US$ 28.88
US$ 28.16
US$ 24.33
US$ 29.09
US$ 29.12
US$ 23.99
